{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:08:12Z","timestamp":1788469692256,"version":"build-2803163510"},"reference-count":238,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11095-020-02849-1","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T16:02:45Z","timestamp":1591891365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls"],"prefix":"10.1007","volume":"37","author":[{"given":"T. P. Tim","family":"Cushnie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamart","family":"Cushnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winita","family":"Fowsantear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutthiwan","family":"Thammawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyon L.A.","family":"Dodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Clow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"2849_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B. Antibiotics: Past, present and future. Curr Opin Microbiol. 2019;51:72\u201380.","journal-title":"Curr Opin Microbiol"},{"key":"2849_CR2","doi-asserted-by":"crossref","unstructured":"De Mattos-Shipley KMJ, Foster GD, Bailey AM. Insights into the classical genetics of Clitopilus passeckerianus - the pleuromutilin producing mushroom. Front Microbiol. 2017;8:Article 1056.","DOI":"10.3389\/fmicb.2017.01056"},{"issue":"2","key":"2849_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bmcl.2013.12.059","volume":"24","author":"DG Brown","year":"2014","unstructured":"Brown DG, Lister T, May-Dracka TL. New natural products as new leads for antibacterial drug discovery. Bioorg Med Chem Lett. 2014;24(2):413\u20138.","journal-title":"Bioorg Med Chem Lett."},{"key":"2849_CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2016.11.002","volume":"134","author":"K Lewis","year":"2017","unstructured":"Lewis K. New approaches to antimicrobial discovery. Biochem Pharmacol. 2017;134:87\u201398.","journal-title":"Biochem Pharmacol."},{"issue":"3","key":"2849_CR5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dks436","volume":"68","author":"I Chopra","year":"2013","unstructured":"Chopra I. The 2012 Garrod Lecture: Discovery of antibacterial drugs in the 21st century. J Antimicrob Chemother. 2013;68(3):496\u2013505.","journal-title":"J Antimicrob Chemother."},{"issue":"6","key":"2849_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17460441.2018.1455660","volume":"13","author":"D Benedetto Tiz","year":"2018","unstructured":"Benedetto Tiz D, Kikelj D, Zidar N. Overcoming problems of poor drug penetration into bacteria: Challenges and strategies for medicinal chemists. Expert Opin Drug Discov. 2018;13(6):497\u2013507.","journal-title":"Expert Opin Drug Discov."},{"key":"2849_CR7","doi-asserted-by":"crossref","unstructured":"Ribeiro da Cunha B, Fonseca LP, Calado CRC. Antibiotic discovery: Where have we come from, where do we go? Antibiotics. 2019;8(2):Article 45.","DOI":"10.3390\/antibiotics8020045"},{"key":"2849_CR8","unstructured":"Jacobs A. Crisis looms in antibiotics as drug makers go bankrupt. The New York Times. 2019. Available from: https:\/\/www.nytimes.com\/2019\/12\/25\/health\/antibiotics-new-resistance.html. Accessed 30 May 2020."},{"issue":"1","key":"2849_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","volume":"24","author":"LL Silver","year":"2011","unstructured":"Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev. 2011;24(1):71\u2013109.","journal-title":"Clin Microbiol Rev."},{"issue":"4","key":"2849_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijantimicag.2018.11.010","volume":"53","author":"GA Durand","year":"2019","unstructured":"Durand GA, Raoult D, Dubourg G. Antibiotic discovery: History, methods and perspectives. Int J Antimicrob Agents. 2019;53(4):371\u201382.","journal-title":"Int J Antimicrob Agents."},{"issue":"2","key":"2849_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","volume":"73","author":"SA Dingsdag","year":"2017","unstructured":"Dingsdag SA, Hunter N. Metronidazole: An update on metabolism, structure-cytotoxicity and resistance mechanisms. J Antimicrob Chemother. 2017;73(2):265\u201379.","journal-title":"J Antimicrob Chemother."},{"key":"2849_CR12","doi-asserted-by":"crossref","unstructured":"Andersson MI, MacGowan AP. Development of the quinolones. J Antimicrob Chemother. 2003;51(Supplement 1):1-11.","DOI":"10.1093\/jac\/dkg212"},{"issue":"2","key":"2849_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111\u201329.","journal-title":"Nat Rev Drug Discov."},{"issue":"24","key":"2849_CR14","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1016\/j.bmc.2016.09.014","volume":"24","author":"TA Wencewicz","year":"2016","unstructured":"Wencewicz TA. New antibiotics from Nature's chemical inventory. Bioorg Med Chem. 2016;24(24):6227\u201352.","journal-title":"Bioorg Med Chem."},{"issue":"4","key":"2849_CR15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1179\/2047773212Y.0000000033","volume":"106","author":"S Lee","year":"2012","unstructured":"Lee S, Siddiqui R, Khan NA. Animals living in polluted environments are potential source of antimicrobials against infectious agents. Pathog Glob Health. 2012;106(4):218\u201323.","journal-title":"Pathog Glob Health."},{"issue":"2","key":"2849_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10295-015-1723-5","volume":"43","author":"L Katz","year":"2016","unstructured":"Katz L, Baltz RH. Natural product discovery: Past, present, and future. J Ind Microbiol Biotechnol. 2016;43(2):155\u201376.","journal-title":"J Ind Microbiol Biotechnol."},{"issue":"3","key":"2849_CR17","first-page":"125","volume":"2","author":"RH Baltz","year":"2007","unstructured":"Baltz RH. Antimicrobials from actinomycetes: Back to the future. Microbe. 2007;2(3):125\u201331.","journal-title":"Microbe."},{"key":"2849_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2017.01.003","volume":"133","author":"SB Singh","year":"2017","unstructured":"Singh SB, Young K, Silver LL. What is an \"ideal\" antibiotic? Discovery challenges and path forward. Biochem Pharmacol. 2017;133:63\u201373.","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"2849_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10482-014-0204-6","volume":"106","author":"O Genilloud","year":"2014","unstructured":"Genilloud O. The re-emerging role of microbial natural products in antibiotic discovery. Antonie van Leeuwenhoek. 2014;106(1):173\u201388.","journal-title":"Antonie van Leeuwenhoek."},{"key":"2849_CR20","unstructured":"British Society for Antimicrobial Chemotherapy (BSAC). AntibioticDB. BSAC. 2020. Available from: https:\/\/www.antibioticdb.com\/. Accessed on: 30 May 2020."},{"key":"2849_CR21","unstructured":"National Library of Medicine. ClinicalTrials.gov. National Institutes of Health. 2020. Available from: https:\/\/clinicaltrials.gov\/. Accessed on: 30 May 2020."},{"issue":"3","key":"2849_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/acsmedchemlett.5b00032","volume":"6","author":"JB Baell","year":"2015","unstructured":"Baell JB. Screening-based translation of public research encounters painful problems. ACS Med Chem Lett. 2015;6(3):229\u201334.","journal-title":"ACS Med Chem Lett."},{"issue":"7","key":"2849_CR23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010;53(7):2719\u201340.","journal-title":"J Med Chem."},{"key":"2849_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4614-1400-1_2","volume-title":"Antibiotic discovery and development","author":"LL Silver","year":"2012","unstructured":"Silver LL. Rational approaches to antibacterial discovery: Pre-genomic directed and phenotypic screening. In: Dougherty TJ, Pucci MJ, editors. Antibiotic discovery and development. New York: Springer; 2012. p. 33\u201375."},{"key":"2849_CR25","doi-asserted-by":"crossref","unstructured":"Kong C, Eng S-A, Lim M-P, Nathan S. Beyond traditional antimicrobials: A Caenorhabditis elegans model for discovery of novel anti-infectives. Front Microbiol. 2016;7:Article 1956.","DOI":"10.3389\/fmicb.2016.01956"},{"issue":"3","key":"2849_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1086\/693564","volume":"92","author":"BB Larsen","year":"2017","unstructured":"Larsen BB, Miller EC, Rhodes MK, Wiens JJ. Inordinate fondness multiplied and redistributed: The number of species on Earth and the new pie of life. Q Rev Biol. 2017;92(3):229\u201365.","journal-title":"Q Rev Biol."},{"issue":"5","key":"2849_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mib.2013.08.001","volume":"16","author":"GF Bills","year":"2013","unstructured":"Bills GF, Gloer JB, An Z. Coprophilous fungi: Antibiotic discovery and functions in an underexplored arena of microbial defensive mutualism. Curr Opin Microbiol. 2013;16(5):549\u201365.","journal-title":"Curr Opin Microbiol."},{"key":"2849_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/82_2016_496","volume-title":"How to overcome the antibiotic crisis: Facts, challenges, technologies and future perspectives","author":"S Karwehl","year":"2016","unstructured":"Karwehl S, Stadler M. Exploitation of fungal biodiversity for discovery of novel antibiotics. In: Stadler M, Dersch P, editors. How to overcome the antibiotic crisis: Facts, challenges, technologies and future perspectives. New York: Springer; 2016. p. 303\u201338."},{"issue":"11","key":"2849_CR29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/jphp.13156","volume":"71","author":"M Adnan","year":"2019","unstructured":"Adnan M, Ali S, Sheikh K, Amber R. Review on antibacterial activity of Himalayan medicinal plants traditionally used to treat pneumonia and tuberculosis. J Pharm Pharmacol. 2019;71(11):1599\u2013625.","journal-title":"J Pharm Pharmacol."},{"issue":"1","key":"2849_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-010617-052703","volume":"58","author":"EJ Buenz","year":"2018","unstructured":"Buenz EJ, Verpoorte R, Bauer BA. The ethnopharmacologic contribution to bioprospecting natural products. Ann Rev Pharmacol Toxicol. 2018;58(1):509\u201330.","journal-title":"Ann Rev Pharmacol Toxicol."},{"key":"2849_CR31","doi-asserted-by":"crossref","unstructured":"Donia MS, Fischbach MA. Small molecules from the human microbiota. Science. 2015;349(6246):Article 1254766.","DOI":"10.1126\/science.1254766"},{"issue":"3","key":"2849_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10295-018-2085-6","volume":"46","author":"MG Chevrette","year":"2019","unstructured":"Chevrette MG, Currie CR. Emerging evolutionary paradigms in antibiotic discovery. J Ind Microbiol Biotechnol. 2019;46(3):257\u201371.","journal-title":"J Ind Microbiol Biotechnol."},{"key":"2849_CR33","doi-asserted-by":"crossref","unstructured":"L. PK, Kandoi S, Misra R, S. V, K. R, Verma RS. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev. 2019;46:1-9.","DOI":"10.1016\/j.cytogfr.2019.04.002"},{"issue":"7","key":"2849_CR34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1039\/C7NP00009J","volume":"34","author":"N Adnani","year":"2017","unstructured":"Adnani N, Rajski SR, Bugni TS. Symbiosis-inspired approaches to antibiotic discovery. Nat Prod Rep. 2017;34(7):784\u2013814.","journal-title":"Nat Prod Rep."},{"issue":"5","key":"2849_CR35","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00253-017-8115-x","volume":"101","author":"R Tanvir","year":"2017","unstructured":"Tanvir R, Javeed A, Bajwa AG. Endophyte bioprospecting in South Asian medicinal plants: An attractive resource for biopharmaceuticals. Appl Microbiol Biotechnol. 2017;101(5):1831\u201344.","journal-title":"Appl Microbiol Biotechnol."},{"issue":"7","key":"2849_CR36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10295-006-0112-5","volume":"33","author":"J Davies","year":"2006","unstructured":"Davies J. Are antibiotics naturally antibiotics? J Ind Microbiol Biotechnol. 2006;33(7):496\u20139.","journal-title":"J Ind Microbiol Biotechnol."},{"issue":"3","key":"2849_CR37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/mmi.14471","volume":"113","author":"G Pishchany","year":"2020","unstructured":"Pishchany G, Kolter R. On the possible ecological roles of antimicrobials. Mol Microbiol. 2020;113(3):580\u20137.","journal-title":"Mol Microbiol."},{"issue":"2","key":"2849_CR38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0192623312466451","volume":"41","author":"JK Dunnick","year":"2012","unstructured":"Dunnick JK, Nyska A. The toxicity and pathology of selected dietary herbal medicines. Toxicol Pathol. 2012;41(2):374\u201386.","journal-title":"Toxicol Pathol."},{"issue":"Suppl 6","key":"2849_CR39","first-page":"30","volume":"15","author":"CL Lam","year":"2009","unstructured":"Lam CL, Wong W, Fong DY. Chinese herbal medicine in the treatment of acute upper respiratory tract infection: A randomised, double blind, placebo-controlled clinical trial. Hong Kong Med J. 2009;15(Suppl 6):30\u20134.","journal-title":"Hong Kong Med J."},{"issue":"8","key":"2849_CR40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10482-018-1088-7","volume":"111","author":"M Goodfellow","year":"2018","unstructured":"Goodfellow M, Nouioui I, Sanderson R, Xie F, Bull AT. Rare taxa and dark microbial matter: Novel bioactive actinobacteria abound in Atacama Desert soils. Antonie van Leeuwenhoek. 2018;111(8):1315\u201332.","journal-title":"Antonie van Leeuwenhoek."},{"key":"2849_CR41","doi-asserted-by":"crossref","unstructured":"Rangseekaew P, Pathom-Aree W. Cave actinobacteria as producers of bioactive metabolites. Front Microbiol. 2019;10:Article 387.","DOI":"10.3389\/fmicb.2019.00387"},{"issue":"3","key":"2849_CR42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/07388551.2019.1710457","volume":"40","author":"P Stincone","year":"2020","unstructured":"Stincone P, Brandelli A. Marine bacteria as source of antimicrobial compounds. Crit Rev Biotechnol. 2020;40(3):306\u201319.","journal-title":"Crit Rev Biotechnol."},{"key":"2849_CR43","doi-asserted-by":"crossref","unstructured":"Racine E, Gualtieri M. From worms to drug candidate: The story of odilorhabdins, a new class of antimicrobial agents. Front Microbiol. 2019;10:Article 2893.","DOI":"10.3389\/fmicb.2019.02893"},{"issue":"3","key":"2849_CR44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jam.14386","volume":"128","author":"AM Sayed","year":"2020","unstructured":"Sayed AM, Hassan MHA, Alhadrami HA, Hassan HM, Goodfellow M, Rateb ME. Extreme environments: Microbiology leading to specialized metabolites. J Appl Microbiol. 2020;128(3):630\u201357.","journal-title":"J Appl Microbiol."},{"issue":"42","key":"2849_CR45","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1002\/chem.201001279","volume":"16","author":"CC Hughes","year":"2010","unstructured":"Hughes CC, Fenical W. Antibacterials from the sea. Chemistry. 2010;16(42):12512\u201325.","journal-title":"Chemistry."},{"key":"2849_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2019.01.001","volume":"51","author":"L Foulston","year":"2019","unstructured":"Foulston L. Genome mining and prospects for antibiotic discovery. Curr Opin Microbiol. 2019;51:1\u20138.","journal-title":"Curr Opin Microbiol."},{"key":"2849_CR47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.copbio.2017.02.008","volume":"48","author":"H Ren","year":"2017","unstructured":"Ren H, Wang B, Zhao H. Breaking the silence: New strategies for discovering novel natural products. Curr Opin Biotechnol. 2017;48:21\u20137.","journal-title":"Curr Opin Biotechnol."},{"key":"2849_CR48","unstructured":"Secretariat of the Convention on Biological Diversity. The Convention on Biological Diversity. 1992. Available from: https:\/\/www.cbd.int\/convention\/. Accessed on: 30 May 2020."},{"key":"2849_CR49","unstructured":"Secretariat of the Convention on Biological Diversity. The Nagoya Protocol on Access and Benefit-Sharing. 2010. Available from: https:\/\/www.cbd.int\/abs\/. Accessed on: 30 May 2020."},{"key":"2849_CR50","unstructured":"Secretariat of the Convention on Biological Diversity. The Access and Benefit-Sharing Clearing-House (ABSCH). 2020. Available from: https:\/\/absch.cbd.int\/. Accessed on: 30 May 2020."},{"key":"2849_CR51","doi-asserted-by":"crossref","unstructured":"Lee S, Jung PE, Lee Y. Publicly-funded biobanks and networks in East Asia. SpringerPlus. 2016;5(1):Article 1080.","DOI":"10.1186\/s40064-016-2723-2"},{"issue":"7","key":"2849_CR52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/yea.3171","volume":"33","author":"KL Boundy-Mills","year":"2016","unstructured":"Boundy-Mills KL, Glantschnig E, Roberts IN, Yurkov A, Casaregola S, Daniel H-M, et al. Yeast culture collections in the twenty-first century: New opportunities and challenges. Yeast. 2016;33(7):243\u201360.","journal-title":"Yeast."},{"key":"2849_CR53","unstructured":"United Nations Division for Ocean Affairs and the Law of the Sea (DOALOS). United Nations Convention on the Law of the Sea. DOALOS. 1982. Available from: http:\/\/www.un.org\/depts\/los\/convention_agreements\/convention_overview_convention.htm. Accessed on: 30 May 2020."},{"key":"2849_CR54","unstructured":"Secretariat of the Antarctic Treaty. The Protocol on Environmental Protection to the Antarctic Treaty. 1991. Available from: http:\/\/www.ats.aq\/e\/protocol.html. Accessed on: 30 May 2020."},{"issue":"1","key":"2849_CR55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1525\/hsns.2012.42.1.30","volume":"42","author":"E Benson","year":"2012","unstructured":"Benson E. Endangered science: The regulation of research by the U.S. Marine Mammal Protection and Endangered Species Acts. Hist Stud Nat Sci. 2012;42(1):30\u201361.","journal-title":"Hist Stud Nat Sci."},{"issue":"6","key":"2849_CR56","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/bjc.2014.166","volume":"111","author":"RJ Geraghty","year":"2014","unstructured":"Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, et al. Guidelines for the use of cell lines in biomedical research. Brit J Cancer. 2014;111(6):1021\u201346.","journal-title":"Brit J Cancer."},{"issue":"3","key":"2849_CR57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1099\/mic.0.000425","volume":"163","author":"D Smith","year":"2017","unstructured":"Smith D, Da Silva M, Jackson J, Lyal C. Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology. Microbiology. 2017;163(3):289\u201396.","journal-title":"Microbiology."},{"key":"2849_CR58","unstructured":"Heinrich M, Scotti F, Andrade-Cetto A, Berger-Gonz\u00e1lez M, Echeverr\u00eda J, Friso F, et al. Access and benefit sharing under the Nagoya Protocol \u2013 quo vadis? Six Latin American case studies assessing opportunities and risk. Front Pharmacol. in press."},{"issue":"1","key":"2849_CR59","first-page":"1","volume":"6","author":"RA Bye Jr","year":"1986","unstructured":"Bye RA Jr. Voucher specimens in ethnobiological studies and publications. J Ethnobiol. 1986;6(1):1\u20138.","journal-title":"J Ethnobiol."},{"issue":"3","key":"2849_CR60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00222939800770191","volume":"32","author":"JT Huber","year":"1998","unstructured":"Huber JT. The importance of voucher specimens, with practical guidelines for preserving specimens of the major invertebrate phyla for identification. J Nat Hist. 1998;32(3):367\u201385.","journal-title":"J Nat Hist."},{"key":"2849_CR61","doi-asserted-by":"crossref","unstructured":"Turney S, Cameron ER, Cloutier CA, Buddle CM. Non-repeatable science: Assessing the frequency of voucher specimen deposition reveals that most arthropod research cannot be verified. PeerJ. 2015;3:Article 1168.","DOI":"10.7717\/peerj.1168"},{"issue":"2","key":"2849_CR62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ilar.52.2.196","volume":"52","author":"JE Cooper","year":"2011","unstructured":"Cooper JE. Anesthesia, analgesia, and euthanasia of invertebrates. ILAR J. 2011;52(2):196\u2013204.","journal-title":"ILAR J."},{"key":"2849_CR63","volume-title":"Reptile biodiversity: Standard methods for inventory and monitoring","year":"2012","unstructured":"McDiarmid RW, Foster MS, Guyer C, Gibbons JW, Chernoff N, editors. Reptile biodiversity: Standard methods for inventory and monitoring. Los Angeles: University of California Press; 2012."},{"key":"2849_CR64","doi-asserted-by":"crossref","unstructured":"Caulfield T, Murdoch B. Genes, cells, and biobanks: Yes, there's still a consent problem. PLOS Biol. 2017;15(7):Article e2002654.","DOI":"10.1371\/journal.pbio.2002654"},{"issue":"1","key":"2849_CR65","first-page":"30","volume":"1","author":"SW Eisenman","year":"2012","unstructured":"Eisenman SW, Tucker AO, Struwe L. Voucher specimens are essential for documenting source material used in medicinal plant investigations. J Med Act Plants. 2012;1(1):30\u201343.","journal-title":"J Med Act Plants."},{"issue":"14","key":"2849_CR66","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1055\/s-0034-1383001","volume":"80","author":"P Kiuru","year":"2014","unstructured":"Kiuru P, D'Auria MV, Muller CD, Tammela P, Vuorela H, Yli-Kauhaluoma J. Exploring marine resources for bioactive compounds. Planta Med. 2014;80(14):1234\u201346.","journal-title":"Planta Med."},{"key":"2849_CR67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sajb.2012.05.009","volume":"82","author":"B Ncube","year":"2012","unstructured":"Ncube B, Finnie JF, Van Staden J. Quality from the field: The impact of environmental factors as quality determinants in medicinal plants. S Afr J Bot. 2012;82:11\u201320.","journal-title":"S Afr J Bot."},{"key":"2849_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.10.010","volume":"134","author":"E Martinez-Klimova","year":"2017","unstructured":"Martinez-Klimova E, Rodr\u00edguez-Pe\u00f1a K, S\u00e1nchez S. Endophytes as sources of antibiotics. Biochem Pharmacol. 2017;134:1\u201317.","journal-title":"Biochem Pharmacol."},{"issue":"2","key":"2849_CR69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/07388551.2011.562482","volume":"32","author":"K Tiwari","year":"2012","unstructured":"Tiwari K, Gupta RK. Rare actinomycetes: A potential storehouse for novel antibiotics. Crit Rev Biotechnol. 2012;32(2):108\u201332.","journal-title":"Crit Rev Biotechnol."},{"key":"2849_CR70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcp.2016.11.021","volume":"134","author":"GB Mahajan","year":"2017","unstructured":"Mahajan GB, Balachandran L. Sources of antibiotics: Hot springs. Biochem Pharmacol. 2017;134:35\u201341.","journal-title":"Biochem Pharmacol."},{"key":"2849_CR71","doi-asserted-by":"crossref","unstructured":"Tortorella E, Tedesco P, Palma Esposito F, January GG, Fani R, Jaspars M, et al. Antibiotics from deep-sea microorganisms: Current discoveries and perspectives. Mar Drugs. 2018;16(10):Article 355.","DOI":"10.3390\/md16100355"},{"key":"2849_CR72","doi-asserted-by":"crossref","unstructured":"Subramani R, Sipkema D. Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products. Mar Drugs. 2019;17(5):Article 249.","DOI":"10.3390\/md17050249"},{"key":"2849_CR73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-59745-423-0_18","volume-title":"Methods in biobanking","author":"R Tedeschi","year":"2011","unstructured":"Tedeschi R, De Paoli P. Collection and preservation of frozen microorganisms. In: Dillner J, editor. Methods in biobanking. Totowa: Humana Press; 2011. p. 313\u201326."},{"key":"2849_CR74","doi-asserted-by":"crossref","unstructured":"Pilaquinga F, Morej\u00f3n B, Ganchala D, Morey J, Pi\u00f1a N, Debut A, et al. Green synthesis of silver nanoparticles using Solanum mammosum L. (Solanaceae) fruit extract and their larvicidal activity against Aedes aegypti L. (Diptera: Culicidae). PLOS ONE. 2019;14(10):Article 0224109.","DOI":"10.1371\/journal.pone.0224109"},{"key":"2849_CR75","first-page":"257","volume-title":"Museum studies: Perspectives and innovations","author":"M Kageyama","year":"2007","unstructured":"Kageyama M, Monk RR, Bradley RD, Edson GF, Baker RJ. The changing significance and definition of the biological voucher. In: Williams SL, Hawks CA, editors. Museum studies: Perspectives and innovations. Washington: Society for the Preservation of Natural History Collections; 2007. p. 257\u201364."},{"issue":"2","key":"2849_CR76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10123-003-0114-3","volume":"6","author":"D Smith","year":"2003","unstructured":"Smith D. Culture collections over the world. Int Microbiol. 2003;6(2):95\u2013100.","journal-title":"Int Microbiol."},{"key":"2849_CR77","doi-asserted-by":"crossref","unstructured":"Culley TM. Why vouchers matter in botanical research. Appl Plant Sci. 2013;1(11):Article 1300076.","DOI":"10.3732\/apps.1300076"},{"issue":"11","key":"2849_CR78","first-page":"1511","volume":"4","author":"VC Verma","year":"2009","unstructured":"Verma VC, Kharwar RN, Strobel GA. Chemical and functional diversity of natural products from plant associated endophytic fungi. Nat Prod Commun. 2009;4(11):1511\u201332.","journal-title":"Nat Prod Commun."},{"key":"2849_CR79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biochi.2015.06.004","volume":"118","author":"A Besse","year":"2015","unstructured":"Besse A, Peduzzi J, Rebuffat S, Carr\u00e9-Mlouka A. Antimicrobial peptides and proteins in the face of extremes: Lessons from archaeocins. Biochimie. 2015;118:344\u201355.","journal-title":"Biochimie."},{"issue":"4","key":"2849_CR80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrmicro2977","volume":"11","author":"DM Cornforth","year":"2013","unstructured":"Cornforth DM, Foster KR. Competition sensing: The social side of bacterial stress responses. Nat Rev Microbiol. 2013;11(4):285\u201393.","journal-title":"Nat Rev Microbiol."},{"issue":"3","key":"2849_CR81","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/femsre\/fux005","volume":"41","author":"A Van der Meij","year":"2017","unstructured":"Van der Meij A, Worsley SF, Hutchings MI, Van Wezel GP. Chemical ecology of antibiotic production by actinomycetes. FEMS Microbiol Rev. 2017;41(3):392\u2013416.","journal-title":"FEMS Microbiol Rev."},{"issue":"3-4","key":"2849_CR82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1515\/znc-2010-3-401","volume":"65","author":"K Moln\u00e1r","year":"2010","unstructured":"Moln\u00e1r K, Farkas E. Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch C. 2010;65(3-4):157\u201373.","journal-title":"Z Naturforsch C."},{"key":"2849_CR83","doi-asserted-by":"crossref","unstructured":"Djinni I, Defant A, Kecha M, Mancini I. Actinobacteria derived from Algerian ecosystems as a prominent source of antimicrobial molecules. Antibiotics. 2019;8(4):Article E172.","DOI":"10.3390\/antibiotics8040172"},{"key":"2849_CR84","doi-asserted-by":"crossref","unstructured":"Alcayaga-Miranda F, Cuenca J, Khoury M. Antimicrobial activity of mesenchymal stem cells: Current status and new perspectives of antimicrobial peptide-based therapies. Front Immunol. 2017;8:Article 339.","DOI":"10.3389\/fimmu.2017.00339"},{"key":"2849_CR85","doi-asserted-by":"crossref","unstructured":"Manteca \u00c1, Yag\u00fce P. Streptomyces differentiation in liquid cultures as a trigger of secondary metabolism. Antibiotics. 2018;7(2):Article 41.","DOI":"10.3390\/antibiotics7020041"},{"issue":"8","key":"2849_CR86","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.3390\/ijms10083400","volume":"10","author":"R Gonz\u00e1lez-Lamothe","year":"2009","unstructured":"Gonz\u00e1lez-Lamothe R, Mitchell G, Gattuso M, Diarra MS, Malouin F, Bouarab K. Plant antimicrobial agents and their effects on plant and human pathogens. Int J Mol Sci. 2009;10(8):3400\u201319.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"2849_CR87","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ibmb.2011.05.007","volume":"41","author":"NA Ratcliffe","year":"2011","unstructured":"Ratcliffe NA, Mello CB, Garcia ES, Butt TM, Azambuja P. Insect natural products and processes: New treatments for human disease. Insect Biochem Mol Biol. 2011;41(10):747\u201369.","journal-title":"Insect Biochem Mol Biol."},{"key":"2849_CR88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mib.2018.04.002","volume":"45","author":"T Netzker","year":"2018","unstructured":"Netzker T, Flak M, Krespach MKC, Stroe MC, Weber J, Schroeckh V, et al. Microbial interactions trigger the production of antibiotics. Curr Opin Microbiol. 2018;45:117\u201323.","journal-title":"Curr Opin Microbiol."},{"issue":"12","key":"2849_CR89","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/nbt1206-1504","volume":"24","author":"K Lewis","year":"2006","unstructured":"Lewis K, Ausubel FM. Prospects for plant-derived antibacterials. Nat Biotechnol. 2006;24(12):1504\u20137.","journal-title":"Nat Biotechnol."},{"key":"2849_CR90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/0-387-23266-4_2","volume-title":"Multigenic and induced systemic resistance in plants","author":"J Ku\u0107","year":"2006","unstructured":"Ku\u0107 J. What's old and what's new in concepts of induced systemic resistance in plants, and its application. In: Tuzun S, Bent E, editors. Multigenic and induced systemic resistance in plants. Boston: Springer; 2006. p. 9\u201320."},{"issue":"3","key":"2849_CR91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/insects4030320","volume":"4","author":"\u00c1M Casanova-Torres","year":"2013","unstructured":"Casanova-Torres \u00c1M, Goodrich-Blair H. Immune signaling and antimicrobial peptide expression in Lepidoptera. Insects. 2013;4(3):320\u201338.","journal-title":"Insects."},{"key":"2849_CR92","doi-asserted-by":"crossref","unstructured":"De Moraes CN, Maia L, De Oliveira E, De Paula Freitas Dell'Aqua C, Chapwanya A, Da Cruz Landim-Alvarenga F, et al. Shotgun proteomic analysis of the secretome of bovine endometrial mesenchymal progenitor\/stem cells challenged or not with bacterial lipopolysaccharide. Vet Immunol Immunopathol. 2017;187:42-47.","DOI":"10.1016\/j.vetimm.2017.03.007"},{"key":"2849_CR93","unstructured":"Hosseiniyan Khatibi SM, Kheyrolahzadeh K, Barzegari A, Rahbar Saadat Y, Vahed SZ. Medicinal signaling cells: A potential antimicrobial drug store. J Cell Physiol. in press."},{"key":"2849_CR94","doi-asserted-by":"crossref","unstructured":"Sutton MT, Fletcher D, Ghosh SK, Weinberg A, Van Heeckeren R, Kaur S, et al. Antimicrobial properties of mesenchymal stem cells: Therapeutic potential for cystic fibrosis infection, and treatment. Stem Cells Int. 2016;2016:Article 5303048.","DOI":"10.1155\/2016\/5303048"},{"key":"2849_CR95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mib.2019.06.006","volume":"51","author":"C Zhang","year":"2019","unstructured":"Zhang C, Straight PD. Antibiotic discovery through microbial interactions. Curr Opin Microbiol. 2019;51:64\u201371.","journal-title":"Curr Opin Microbiol."},{"issue":"21","key":"2849_CR96","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1128\/JB.00425-15","volume":"197","author":"TT Truong","year":"2015","unstructured":"Truong TT, Seyedsayamdost M, Greenberg EP, Chandler JR. A Burkholderia thailandensis acyl-homoserine lactone-independent LuxR homolog that activates production of the cytotoxin malleilactone. J Bacteriol. 2015;197(21):3456\u201362.","journal-title":"J Bacteriol."},{"key":"2849_CR97","doi-asserted-by":"crossref","unstructured":"Newman D. Screening and identification of novel biologically active natural compounds. F1000Research. 2017;6:Article 783.","DOI":"10.12688\/f1000research.11221.1"},{"key":"2849_CR98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ja.2016.127","volume":"70","author":"K Ueda","year":"2016","unstructured":"Ueda K, Beppu T. Antibiotics in microbial coculture. J Antibiot. 2016;70:361\u20135.","journal-title":"J Antibiot."},{"issue":"2","key":"2849_CR99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10295-013-1349-4","volume":"41","author":"K Ochi","year":"2014","unstructured":"Ochi K, Tanaka Y, Tojo S. Activating the expression of bacterial cryptic genes by rpoB mutations in RNA polymerase or by rare earth elements. J Ind Microbiol Biotechnol. 2014;41(2):403\u201314.","journal-title":"J Ind Microbiol Biotechnol."},{"issue":"1","key":"2849_CR100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ddr.21482","volume":"80","author":"J Wiese","year":"2019","unstructured":"Wiese J, Imhoff JF. Marine bacteria and fungi as promising source for new antibiotics. Drug Dev Res. 2019;80(1):24\u20137.","journal-title":"Drug Dev Res."},{"issue":"10","key":"2849_CR101","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/eci.12667","volume":"46","author":"MM Kasiri","year":"2016","unstructured":"Kasiri MM, Beer L, Nemec L, Gruber F, Pietkiewicz S, Haider T, et al. Dying blood mononuclear cell secretome exerts antimicrobial activity. Eur J Clin Invest. 2016;46(10):853\u201363.","journal-title":"Eur J Clin Invest."},{"key":"2849_CR102","volume-title":"Natural products isolation, 2nd edn","year":"2006","unstructured":"Sarker SD, Latif Z, Gray AI, editors. Natural products isolation, 2nd edn. Totowa: Humana Press; 2006."},{"issue":"6","key":"2849_CR103","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-2008-1074518","volume":"74","author":"S Gibbons","year":"2008","unstructured":"Gibbons S. Phytochemicals for bacterial resistance - strengths, weaknesses and opportunities. Planta Med. 2008;74(6):594\u2013602.","journal-title":"Planta Med."},{"issue":"5","key":"2849_CR104","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijantimicag.2014.06.001","volume":"44","author":"TPT Cushnie","year":"2014","unstructured":"Cushnie TPT, Cushnie B, Lamb AJ. Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int J Antimicrob Agents. 2014;44(5):377\u201386.","journal-title":"Int J Antimicrob Agents."},{"issue":"4","key":"2849_CR105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1039\/c3np20106f","volume":"30","author":"F Bucar","year":"2013","unstructured":"Bucar F, Wube A, Schmid M. Natural product isolation - How to get from biological material to pure compounds. Nat Prod Rep. 2013;30(4):525\u201345.","journal-title":"Nat Prod Rep."},{"issue":"1","key":"2849_CR106","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1248\/cpb.55.140","volume":"55","author":"S-L Li","year":"2007","unstructured":"Li S-L, Yan R, Tam Y-K, Lin G. Post-harvest alteration of the main chemical ingredients in Ligusticum chuanxiong Hort. (Rhizoma Chuanxiong). Chem Pharm Bull. 2007;55(1):140\u20134.","journal-title":"Chem Pharm Bull."},{"key":"2849_CR107","doi-asserted-by":"crossref","unstructured":"Lang K, Corr\u00eaa J, Wolff F, Da Silva GF, Malheiros A, Filho VC, et al. Biomonitored UHPLC-ESI-QTOF-MS2 and HPLC-UV thermostability study of the aerial parts of Sphagneticola trilobata (L.) Pruski, Asteraceae. Talanta. 2017;167:302-309.","DOI":"10.1016\/j.talanta.2017.02.024"},{"issue":"3","key":"2849_CR108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","volume":"106","author":"P Cos","year":"2006","unstructured":"Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol. 2006;106(3):290\u2013302.","journal-title":"J Ethnopharmacol."},{"issue":"3","key":"2849_CR109","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jep.2007.01.032","volume":"110","author":"PJ Houghton","year":"2007","unstructured":"Houghton PJ, Howes M-J, Lee CC, Steventon G. Uses and abuses of in vitro tests in ethnopharmacology: Visualizing an elephant. J Ethnopharmacol. 2007;110(3):391\u2013400.","journal-title":"J Ethnopharmacol."},{"issue":"1","key":"2849_CR110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jep.2004.10.021","volume":"97","author":"GI Stafford","year":"2005","unstructured":"Stafford GI, Jager AK, Van Staden J. Effect of storage on the chemical composition and biological activity of several popular South African medicinal plants. J Ethnopharmacol. 2005;97(1):107\u201315.","journal-title":"J Ethnopharmacol."},{"key":"2849_CR111","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.envres.2015.08.004","volume":"142","author":"CL Cespedes","year":"2015","unstructured":"Cespedes CL, Alarcon J, Aqueveque PM, Lobo T, Becerra J, Balbontin C, et al. New environmentally-friendly antimicrobials and biocides from Andean and Mexican biodiversity. Environ Res. 2015;142:549\u201362.","journal-title":"Environ Res."},{"issue":"14","key":"2849_CR112","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1055\/s-0034-1383061","volume":"80","author":"A Fallarero","year":"2014","unstructured":"Fallarero A, Hanski L, Vuorela P. How to translate a bioassay into a screening assay for natural products: General considerations and implementation of antimicrobial screens. Planta Med. 2014;80(14):1182\u201399.","journal-title":"Planta Med."},{"issue":"11","key":"2849_CR113","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.tibs.2019.05.005","volume":"44","author":"G Niu","year":"2019","unstructured":"Niu G, Li W. Next-generation drug discovery to combat antimicrobial resistance. Trends Biochem Sci. 2019;44(11):961\u201372.","journal-title":"Trends Biochem Sci."},{"issue":"12","key":"2849_CR114","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 2014;52(12):4124\u20138.","journal-title":"J Clin Microbiol."},{"key":"2849_CR115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.foodchem.2014.09.141","volume":"172","author":"JBL Tan","year":"2015","unstructured":"Tan JBL, Lim YY. Critical analysis of current methods for assessing the in vitro antioxidant and antibacterial activity of plant extracts. Food Chem. 2015;172:814\u201322.","journal-title":"Food Chem."},{"key":"2849_CR116","unstructured":"Clinical Laboratory Standards Institute (CLSI). M02-A12 Performance standards for antimicrobial disk susceptibility tests; approved standard, 13th edn. Wayne: CLSI; 2018."},{"key":"2849_CR117","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST disk diffusion test methodology; version 8.0. European Society of Clinical Microbiology and Infectious Diseases. 2020. Available from: https:\/\/www.eucast.org\/ast_of_bacteria\/disk_diffusion_methodology\/. Accessed on: 30 May 2020."},{"key":"2849_CR118","volume-title":"Antibiotics in laboratory medicine, 6th edn","year":"2014","unstructured":"Amsterdam D, editor. Antibiotics in laboratory medicine, 6th edn. London: Wolters Kluwer; 2014."},{"issue":"8","key":"2849_CR119","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/eri.11.81","volume":"9","author":"SB Singh","year":"2011","unstructured":"Singh SB, Young K, Miesel L. Screening strategies for discovery of antibacterial natural products. Expert Rev Anti-infect Ther. 2011;9(8):589\u2013613.","journal-title":"Expert Rev Anti-infect Ther."},{"issue":"24","key":"2849_CR120","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.2174\/15680266113136660219","volume":"13","author":"PRH Moreno","year":"2013","unstructured":"Moreno PRH, Da Costa-Issa FI, Rajca-Ferreira AK, Pereira MA, Kaneko TM. Native Brazilian plants against nosocomial infections: A critical review on their potential and the antimicrobial methodology. Curr Top Med Chem. 2013;13(24):3040\u201378.","journal-title":"Curr Top Med Chem."},{"issue":"1","key":"2849_CR121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jep.2005.04.025","volume":"100","author":"JL R\u00edos","year":"2005","unstructured":"R\u00edos JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 2005;100(1):80\u20134.","journal-title":"J Ethnopharmacol."},{"issue":"5937","key":"2849_CR122","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","volume":"325","author":"JW-H Li","year":"2009","unstructured":"Li JW-H, Vederas JC. Drug discovery and natural products: End of an era or an endless frontier? Science. 2009;325(5937):161\u20135.","journal-title":"Science."},{"issue":"5","key":"2849_CR123","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41589-018-0019-2","volume":"14","author":"J Rajniak","year":"2018","unstructured":"Rajniak J, Giehl R, Chang E, Murgia I, Von Wir\u00e9n N, Sattely E. Biosynthesis of redox-active metabolites in response to iron deficiency in plants. Nat Chem Biol. 2018;14(5):442\u201350.","journal-title":"Nat Chem Biol."},{"issue":"15","key":"2849_CR124","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1055\/s-0035-1546055","volume":"81","author":"THJ Niedermeyer","year":"2015","unstructured":"Niedermeyer THJ. Anti-infective natural products from cyanobacteria. Planta Med. 2015;81(15):1309\u201325.","journal-title":"Planta Med."},{"key":"2849_CR125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxicon.2017.02.020","volume":"130","author":"F Fratini","year":"2017","unstructured":"Fratini F, Cilia G, Turchi B, Felicioli A. Insects, arachnids and centipedes venom: A powerful weapon against bacteria. A literature review. Toxicon. 2017;130:91\u2013103.","journal-title":"Toxicon."},{"key":"2849_CR126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mib.2019.10.012","volume":"51","author":"O Genilloud","year":"2019","unstructured":"Genilloud O. Natural products discovery and potential for new antibiotics. Curr Opin Microbiol. 2019;51:81\u20137.","journal-title":"Curr Opin Microbiol."},{"issue":"2","key":"2849_CR127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpha.2014.06.002","volume":"5","author":"S Dewanjee","year":"2015","unstructured":"Dewanjee S, Gangopadhyay M, Bhattacharya N, Khanra R, Dua TK. Bioautography and its scope in the field of natural product chemistry. J Pharm Anal. 2015;5(2):75\u201384.","journal-title":"J Pharm Anal."},{"key":"2849_CR128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mimet.2016.02.006","volume":"123","author":"JK Kov\u00e1cs","year":"2016","unstructured":"Kov\u00e1cs JK, Horv\u00e1th G, Ker\u00e9nyi M, Kocsis B, Em\u00f6dy L, Schneider G. A modified bioautographic method for antibacterial component screening against anaerobic and microaerophilic bacteria. J Microbiol Methods. 2016;123:13\u20137.","journal-title":"J Microbiol Methods."},{"issue":"2","key":"2849_CR129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/chromatography2020225","volume":"2","author":"MI Choma","year":"2015","unstructured":"Choma MI, Jesionek W. TLC-direct bioautography as a high throughput method for detection of antimicrobials in plants. Chromatography. 2015;2(2):225\u201338.","journal-title":"Chromatography."},{"issue":"2","key":"2849_CR130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/S1517-83822007000200034","volume":"38","author":"C Valgas","year":"2007","unstructured":"Valgas C, Souza SM, Sm\u00e2nia EFA, Sm\u00e2nia A Jr. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol. 2007;38(2):369\u201380.","journal-title":"Braz J Microbiol."},{"issue":"2","key":"2849_CR131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-8741(88)90001-3","volume":"23","author":"JL R\u00edos","year":"1988","unstructured":"R\u00edos JL, Recio MC, Villar A. Screening methods for natural products with antimicrobial activity: A review of the literature. J Ethnopharmacol. 1988;23(2):127\u201349.","journal-title":"J Ethnopharmacol."},{"issue":"2","key":"2849_CR132","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jep.2004.05.012","volume":"94","author":"CW Fennell","year":"2004","unstructured":"Fennell CW, Lindsey KL, McGaw LJ, Sparg SG, Stafford GI, Elgorashi EE, et al. Assessing African medicinal plants for efficacy and safety: Pharmacological screening and toxicology. J Ethnopharmacol. 2004;94(2):205\u201317.","journal-title":"J Ethnopharmacol."},{"key":"2849_CR133","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10989-015-9494-4","volume":"22","author":"M Jaskiewicz","year":"2016","unstructured":"Jaskiewicz M, Orlowska M, Olizarowicz G, Migon D, Grzywacz D, Kamysz W. Rapid screening of antimicrobial synthetic peptides. Int J Pept Res Ther. 2016;22:155\u201361.","journal-title":"Int J Pept Res Ther."},{"issue":"23","key":"2849_CR134","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1007\/s00018-016-2302-2","volume":"73","author":"TPT Cushnie","year":"2016","unstructured":"Cushnie TPT, O'Driscoll NH, Lamb AJ. Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. Cell Mol Life Sci. 2016;73(23):4471\u201392.","journal-title":"Cell Mol Life Sci."},{"key":"2849_CR135","unstructured":"Clinical Laboratory Standards Institute (CLSI). M26-A Methods for determining bactericidal activity of antimicrobial agents; approved guideline. Wayne: CLSI; 1999."},{"issue":"5","key":"2849_CR136","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10412905.2004.9698757","volume":"16","author":"PJ Delaquis","year":"2004","unstructured":"Delaquis PJ, Stanich K. Antilisterial properties of cilantro essential oil. J Essent Oil Res. 2004;16(5):409\u201314.","journal-title":"J Essent Oil Res."},{"key":"2849_CR137","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopha.2017.06.020","volume":"92","author":"FS Oliveira","year":"2017","unstructured":"Oliveira FS, Freitas TS, Cruz RPD, Costa MDS, Pereira RLS, Quintans-J\u00fanior LJ, et al. Evaluation of the antibacterial and modulatory potential of alpha-bisabolol, beta-cyclodextrin and alpha-bisabolol\/beta-cyclodextrin complex. Biomed Pharmacother. 2017;92:1111\u20138.","journal-title":"Biomed Pharmacother."},{"issue":"3","key":"2849_CR138","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10482-012-9777-0","volume":"102","author":"X Liu","year":"2012","unstructured":"Liu X, Chen C, He W, Huang P, Liu M, Wang Q, et al. Exploring anti-TB leads from natural products library originated from marine microbes and medicinal plants. Antonie van Leeuwenhoek. 2012;102(3):447\u201361.","journal-title":"Antonie van Leeuwenhoek."},{"key":"2849_CR139","unstructured":"Clinical Laboratory Standards Institute (CLSI). M07 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 11th edn. Wayne: CLSI; 2018."},{"key":"2849_CR140","unstructured":"International Organization for Standardization (ISO). ISO 20776-1:2019 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. Geneva: ISO; 2019."},{"key":"2849_CR141","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). MIC determination of non-fastidious and fastidious organisms. European Society of Clinical Microbiology and Infectious Diseases. 2020. Available from: http:\/\/www.eucast.org\/ast_of_bacteria\/mic_determination\/. Accessed on: 30 May 2020."},{"key":"2849_CR142","doi-asserted-by":"crossref","unstructured":"Echeverr\u00eda J, Opazo J, Mendoza L, Urz\u00faa A, Wilkens M. Structure-activity and lipophilicity relationships of selected antibacterial natural flavones and flavanones of Chilean flora. Molecules. 2017;22(4):Article 608.","DOI":"10.3390\/molecules22040608"},{"issue":"5","key":"2849_CR143","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt0502-478","volume":"20","author":"JA DeVito","year":"2002","unstructured":"DeVito JA, Mills JA, Liu VG, Agarwal A, Sizemore CF, Yao Z, et al. An array of target-specific screening strains for antibacterial discovery. Nat Biotechnol. 2002;20(5):478\u201383.","journal-title":"Nat Biotechnol."},{"issue":"2","key":"2849_CR144","first-page":"160","volume":"10","author":"SB Singh","year":"2007","unstructured":"Singh SB, Phillips JW, Wang J. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing. Curr Opin Drug Discov Dev. 2007;10(2):160\u20136.","journal-title":"Curr Opin Drug Discov Dev."},{"key":"2849_CR145","doi-asserted-by":"crossref","unstructured":"Van den Driessche F, Rigole P, Brackman G, Coenye T. Optimization of resazurin-based viability staining for quantification of microbial biofilms. J Microbiol Methods. 2014;98(Supplement C):31-34.","DOI":"10.1016\/j.mimet.2013.12.011"},{"key":"2849_CR146","first-page":"15","volume-title":"Advances in microbiology, infectious diseases and public health","author":"G Brackman","year":"2016","unstructured":"Brackman G, Coenye T. In vitro and in vivo biofilm wound models and their application. In: Donelli G, editor. Advances in microbiology, infectious diseases and public health. New York: Springer; 2016. p. 15\u201332."},{"issue":"6","key":"2849_CR147","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/mabi.201500437","volume":"16","author":"G Brackman","year":"2016","unstructured":"Brackman G, Garcia-Fernandez MJ, Lenoir J, De Meyer L, Remon J-P, De Beer T, et al. Dressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities. Macromol Biosci. 2016;16(6):859\u201369.","journal-title":"Macromol Biosci."},{"issue":"3","key":"2849_CR148","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jep.2008.05.038","volume":"119","author":"SF Van Vuuren","year":"2008","unstructured":"Van Vuuren SF. Antimicrobial activity of South African medicinal plants. J Ethnopharmacol. 2008;119(3):462\u201372.","journal-title":"J Ethnopharmacol."},{"key":"2849_CR149","volume-title":"editor. Antibiotics in laboratory medicine, 5th edn","author":"V Lorian","year":"2005","unstructured":"Lorian V. editor. Antibiotics in laboratory medicine, 5th edn. London: Lippincott, Williams, and Wilkins; 2005."},{"issue":"2","key":"2849_CR150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/092986706775197917","volume":"13","author":"K Balakin","year":"2006","unstructured":"Balakin K, Savchuk N, Tetko I. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: Trends, problems and solutions. Curr Med Chem. 2006;13(2):223\u201341.","journal-title":"Curr Med Chem."},{"issue":"12","key":"2849_CR151","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/am.16.12.1953-1954.1968","volume":"16","author":"H Basch","year":"1968","unstructured":"Basch H, Gadebusch HH. In vitro antimicrobial activity of dimethylsulfoxide. Appl Microbiol. 1968;16(12):1953\u20134.","journal-title":"Appl Microbiol."},{"key":"2849_CR152","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mimet.2015.09.019","volume":"118","author":"A Mishra","year":"2015","unstructured":"Mishra A, Dobritsa SV, Crouch M-L, Rabenstein J, Lee JXY, Dhakshinamoorthy S. Establishment and validation of a 384-well antibacterial assay amenable for high-throughput screening and combination testing. J Microbiol Methods. 2015;118:173\u20135.","journal-title":"J Microbiol Methods."},{"key":"2849_CR153","doi-asserted-by":"crossref","unstructured":"Maes J, Verlooy L, Buenafe OE, De Witte PAM, Esguerra CV, Crawford AD. Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae. PLOS ONE. 2012;7(10):Article e43850.","DOI":"10.1371\/journal.pone.0043850"},{"key":"2849_CR154","doi-asserted-by":"crossref","unstructured":"Hu J, Akula N, Wang N. Development of a microemulsion formulation for antimicrobial SecA inhibitors. PLOS ONE. 2016;11(3):Article e0150433.","DOI":"10.1371\/journal.pone.0150433"},{"issue":"3","key":"2849_CR155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1472-765X.2008.02406.x","volume":"47","author":"L Mayaud","year":"2008","unstructured":"Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol. 2008;47(3):167\u201373.","journal-title":"Lett Appl Microbiol."},{"issue":"4","key":"2849_CR156","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jam.13541","volume":"123","author":"L Ghaderi","year":"2017","unstructured":"Ghaderi L, Moghimi R, Aliahmadi A, McClements DJ, Rafati H. Development of antimicrobial nanoemulsion-based delivery systems against selected pathogenic bacteria using a thymol-rich Thymus daenensis essential oil. J Appl Microbiol. 2017;123(4):832\u201340.","journal-title":"J Appl Microbiol."},{"issue":"10","key":"2849_CR157","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2012.59","volume":"65","author":"R Dhondikubeer","year":"2012","unstructured":"Dhondikubeer R, Bera S, Zhanel GG, Schweizer F. Antibacterial activity of amphiphilic tobramycin. J Antibiot. 2012;65(10):495\u20138.","journal-title":"J Antibiot."},{"issue":"10","key":"2849_CR158","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JCM.01454-14","volume":"52","author":"CA Sutherland","year":"2014","unstructured":"Sutherland CA, Nicolau DP. To add or not to add polysorbate 80: Impact on colistin MICs for clinical strains of Enterobacteriaceae and Pseudomonas aeruginosa and quality controls. J Clin Microbiol. 2014;52(10):3810.","journal-title":"J Clin Microbiol."},{"issue":"3","key":"2849_CR159","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis."},{"issue":"10","key":"2849_CR160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41429-019-0205-9","volume":"72","author":"EM Grzelak","year":"2019","unstructured":"Grzelak EM, Choules MP, Gao W, Cai G, Wan B, Wang Y, et al. Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening. J Antibiot. 2019;72(10):719\u201328.","journal-title":"J Antibiot."},{"issue":"11","key":"2849_CR161","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","volume":"14","author":"K Katsuno","year":"2015","unstructured":"Katsuno K, Burrows JN, Duncan K, Van Huijsduijnen RH, Kaneko T, Kita K, et al. Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov. 2015;14(11):751\u20138.","journal-title":"Nat Rev Drug Discov."},{"issue":"6","key":"2849_CR162","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jac\/dkl393","volume":"58","author":"GL French","year":"2006","unstructured":"French GL. Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin. J Antimicrob Chemother. 2006;58(6):1107\u201317.","journal-title":"J Antimicrob Chemother."},{"issue":"10","key":"2849_CR163","first-page":"2291","volume":"68","author":"N Gonzalez","year":"2013","unstructured":"Gonzalez N, Sevillano D, Alou L, Cafini F, Gimenez M-J, Gomez-Lus M-L, et al. Influence of the MBC\/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients. J Antimicrob Chemother. 2013;68(10):2291\u20135.","journal-title":"J Antimicrob Chemother."},{"issue":"2","key":"2849_CR164","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijantimicag.2011.02.014","volume":"38","author":"TPT Cushnie","year":"2011","unstructured":"Cushnie TPT, Lamb AJ. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Agents. 2011;38(2):99\u2013107.","journal-title":"Int J Antimicrob Agents."},{"issue":"1","key":"2849_CR165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1574-6968.2012.02598.x","volume":"333","author":"AE Green","year":"2012","unstructured":"Green AE, Rowlands RS, Cooper RA, Maddocks SE. The effect of the flavonol morin on adhesion and aggregation of Streptococcus pyogenes. FEMS Microbiol Lett. 2012;333(1):54\u20138.","journal-title":"FEMS Microbiol Lett."},{"issue":"8","key":"2849_CR166","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.tips.2016.05.001","volume":"37","author":"MG Moloney","year":"2016","unstructured":"Moloney MG. Natural products as a source for novel antibiotics. Trends Pharmacol Sci. 2016;37(8):689\u2013701.","journal-title":"Trends Pharmacol Sci."},{"key":"2849_CR167","volume-title":"Assay guidance manual","year":"2019","unstructured":"Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, et al., editors. Assay guidance manual. Bethesda: Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2019."},{"key":"2849_CR168","unstructured":"Cotton S. Handle with care \u2013 the world\u2019s five deadliest poisons. The Conversation. 2016. Available from: https:\/\/theconversation.com\/handle-with-care-the-worlds-five-deadliest-poisons-56089. Accessed 30 May 2020."},{"issue":"2","key":"2849_CR169","first-page":"86","volume":"43","author":"IFH Purchase","year":"1998","unstructured":"Purchase IFH, Botham PA, Bruner LH, Flint OP, Frazier JM, Stokes WS. Workshop overview: Scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing. Toxicol Sci. 1998;43(2):86\u2013101.","journal-title":"Toxicol Sci."},{"key":"2849_CR170","doi-asserted-by":"crossref","unstructured":"Bluemel J. Toxicity testing in the 21st century: Challenges and perspectives. J Drug Metab Toxicol. 2012;3(5):Article 1000e112.","DOI":"10.4172\/2157-7609.1000e112"},{"issue":"7","key":"2849_CR171","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11095-016-1942-0","volume":"33","author":"T Hammond","year":"2016","unstructured":"Hammond T, Allen P, Birdsall H. Is there a space-based technology solution to problems with preclinical drug toxicity testing? Pharm Res. 2016;33(7):1545\u201351.","journal-title":"Pharm Res."},{"key":"2849_CR172","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.yrtph.2017.09.023","volume":"90","author":"R Kreiling","year":"2017","unstructured":"Kreiling R, Gehrke H, Broschard TH, Dree\u00dfen B, Eigler D, Hart D, et al. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds. Regul Toxicol Pharmacol. 2017;90:262\u201376.","journal-title":"Regul Toxicol Pharmacol."},{"issue":"3","key":"2849_CR173","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09674845.2009.11730265","volume":"66","author":"JE May","year":"2009","unstructured":"May JE, Xu J, Morse HR, Avent ND, Donaldson C. Toxicity testing: The search for an in vitro alternative to animal testing. Brit J Biomed Sci. 2009;66(3):160\u20135.","journal-title":"Brit J Biomed Sci."},{"issue":"7","key":"2849_CR174","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1139\/cjpp-2015-0459","volume":"94","author":"M Cs\u00f6b\u00f6nyeiov\u00e1","year":"2016","unstructured":"Cs\u00f6b\u00f6nyeiov\u00e1 M, Pol\u00e1k S, Dani\u0161ovic L. Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells. Can J Physiol Pharmacol. 2016;94(7):687\u201394.","journal-title":"Can J Physiol Pharmacol."},{"key":"2849_CR175","doi-asserted-by":"crossref","unstructured":"Pelkonen O. Predictive toxicity: Grand challenges. Front Pharmacol. 2010;1:Article 3.","DOI":"10.3389\/fphar.2010.00003"},{"issue":"1","key":"2849_CR176","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C2TX20051A","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, LeCluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res. 2013;2(1):23\u201339.","journal-title":"Toxicol Res."},{"issue":"3","key":"2849_CR177","first-page":"50","volume":"16","author":"WGEJ Schoonen","year":"2011","unstructured":"Schoonen WGEJ, Westerink WMA, Van de Water FM, Horbach GJ. High content screening for in vitro toxicity testing. Eur Pharm Rev. 2011;16(3):50\u20135.","journal-title":"Eur Pharm Rev."},{"issue":"1","key":"2849_CR178","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","volume":"25","author":"WH Halliwell","year":"1997","unstructured":"Halliwell WH. Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol. 1997;25(1):53\u201360.","journal-title":"Toxicol Pathol."},{"key":"2849_CR179","doi-asserted-by":"crossref","unstructured":"Bernuci ZK, Iwanaga CC, Fernandez-Andrade MC, Lorenzetti BF, Torres-Santos CE, Fai\u00f5es DV, et al. Evaluation of chemical composition and antileishmanial and antituberculosis activities of essential oils of Piper species. Molecules. 2016;21(12):Article 1698.","DOI":"10.3390\/molecules21121698"},{"issue":"14","key":"2849_CR180","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/bph.13744","volume":"174","author":"CS Guy","year":"2017","unstructured":"Guy CS, Tichauer E, Kay GL, Phillips DJ, Bailey TL, Harrison J, et al. Identification of the anti-mycobacterial functional properties of piperidinol derivatives. Brit J Pharmacol. 2017;174(14):2183\u201393.","journal-title":"Brit J Pharmacol."},{"key":"2849_CR181","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejps.2016.10.040","volume":"97","author":"B Chudzik","year":"2017","unstructured":"Chudzik B, Czernel G, Miaskowski A, Gago\u015b M. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro. Eur J Pharm Sci. 2017;97:9\u201321.","journal-title":"Eur J Pharm Sci."},{"issue":"1","key":"2849_CR182","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00430-017-0525-y","volume":"207","author":"S Jaiswal","year":"2018","unstructured":"Jaiswal S, Mishra P. Antimicrobial and antibiofilm activity of curcumin-silver nanoparticles with improved stability and selective toxicity to bacteria over mammalian cells. Med Microbiol Immunol. 2018;207(1):39\u201353.","journal-title":"Med Microbiol Immunol."},{"issue":"8","key":"2849_CR183","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/jac\/dkw107","volume":"71","author":"JS Khara","year":"2016","unstructured":"Khara JS, Priestman M, Uh\u00eda I, Hamilton MS, Krishnan N, Wang Y, et al. Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability. J Antimicrob Chemother. 2016;71(8):2181\u201391.","journal-title":"J Antimicrob Chemother."},{"key":"2849_CR184","unstructured":"Sowmya PV, Poojary B, Kumar V, Vishwanatha U, Shetty P. Fluorinated pyrrole incorporated 2-thiazolyl hydrazone motifs: A new class of antimicrobial and anti tuberculosis agents. Arch Pharm Res. in press."},{"key":"2849_CR185","doi-asserted-by":"crossref","unstructured":"Moreira W, Aziz DB, Dick T. Boromycin kills mycobacterial persisters without detectable resistance. Front Microbiol. 2016;7:Article 199.","DOI":"10.3389\/fmicb.2016.00199"},{"issue":"2","key":"2849_CR186","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acsomega.7b01740","volume":"3","author":"K Mitachi","year":"2018","unstructured":"Mitachi K, Yun HG, Kurosu SM, Eslamimehr S, Lemieux MR, Klaic L, et al. Novel FR-900493 analogues that inhibit the outgrowth of Clostridium difficile spores. ACS Omega. 2018;3(2):1726\u201339.","journal-title":"ACS Omega."},{"key":"2849_CR187","doi-asserted-by":"crossref","unstructured":"Kr\u00e1tk\u00fd M, Dzurkov\u00e1 M, Janou\u0161ek J, Kone\u010dn\u00e1 K, Trejtnar F, Stolar\u00edkov\u00e1 J, et al. Sulfadiazine salicylaldehyde-based Schiff bases: Synthesis, antimicrobial activity and cytotoxicity. Molecules. 2017;22(9):Article 1573.","DOI":"10.3390\/molecules22091573"},{"issue":"1","key":"2849_CR188","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bmc.2017.11.018","volume":"26","author":"J Kwon","year":"2018","unstructured":"Kwon J, Mistry T, Ren J, Johnson ME, Mehboob S. A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii. Bioorg Med Chem. 2018;26(1):65\u201376.","journal-title":"Bioorg Med Chem."},{"issue":"8","key":"2849_CR189","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00204-015-1651-1","volume":"90","author":"X Li","year":"2016","unstructured":"Li X, Zhang R, Zhao B, Lossin C, Cao Z. Cardiotoxicity screening: A review of rapid-throughput in vitro approaches. Arch Toxicol. 2016;90(8):1803\u201316.","journal-title":"Arch Toxicol."},{"issue":"12","key":"2849_CR190","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/17512433.2016.1245142","volume":"9","author":"RM Lester","year":"2016","unstructured":"Lester RM, Olbertz J. Early drug development: Assessment of proarrhythmic risk and cardiovascular safety. Expert Rev Clin Pharmacol. 2016;9(12):1611\u20138.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"2849_CR191","doi-asserted-by":"crossref","unstructured":"Roggen EL. In vitro toxicity testing in the twenty-first century. Front Pharmacol. 2011;2:Article 3.","DOI":"10.3389\/fphar.2011.00003"},{"key":"2849_CR192","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/978-1-62703-742-6_34","volume-title":"Optimization in drug discovery: In vitro methods","author":"N Mei","year":"2014","unstructured":"Mei N, Guo X, Moore MM. Methods for using the mouse lymphoma assay to screen for chemical mutagenicity and photo-mutagenicity. In: Caldwell GW, Yan Z, editors. Optimization in drug discovery: In vitro methods. Totowa: Humana Press; 2014. p. 561\u201392."},{"key":"2849_CR193","unstructured":"Organisation for Economic Co-operation and Development (OECD). OECD iLibrary. OECD. 2020. Available from: https:\/\/www.oecd-ilibrary.org\/oecd\/about. Accessed on: 30 May 2020."},{"issue":"1","key":"2849_CR194","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/17425255.2014.854329","volume":"10","author":"A Anad\u00f3n","year":"2014","unstructured":"Anad\u00f3n A, Mart\u00ednez MA, Castellano V, Mart\u00ednez-Larra\u00f1aga MR. The role of in vitro methods as alternatives to animals in toxicity testing. Expert Opin Drug Metab Toxicol. 2014;10(1):67\u201379.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"2849_CR195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-108-6_12","volume-title":"Mammalian cell viability: Methods and protocols","author":"TL Riss","year":"2011","unstructured":"Riss TL, Moravec RA, Niles AL. Cytotoxicity testing: Measuring viable cells, dead cells, and detecting mechanism of cell death. In: Stoddart MJ, editor. Mammalian cell viability: Methods and protocols. Totowa: Humana Press; 2011. p. 103\u201314."},{"key":"2849_CR196","first-page":"1","volume-title":"Genotoxicity - a predictable risk to our actual world","author":"\u00d6S Aslant\u00fcrk","year":"2017","unstructured":"Aslant\u00fcrk \u00d6S. Chapter 1: In vitro cytotoxicity and cell viability assays: Principles, advantages, and disadvantages. In: Genotoxicity - a predictable risk to our actual world. London: IntechOpen; 2017. p. 1\u201317."},{"issue":"4","key":"2849_CR197","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.tiv.2008.02.013","volume":"22","author":"M-H Cho","year":"2008","unstructured":"Cho M-H, Niles A, Huang R, Inglese J, Austin CP, Riss T, et al. A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker. Toxicol in Vitro. 2008;22(4):1099\u2013106.","journal-title":"Toxicol in Vitro."},{"issue":"3","key":"2849_CR198","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.tiv.2012.01.002","volume":"26","author":"M Vinken","year":"2012","unstructured":"Vinken M, Vanhaecke T, Rogiers V. Primary hepatocyte cultures as in vitro tools for toxicity testing: Quo vadis? Toxicol in Vitro. 2012;26(3):541\u20134.","journal-title":"Toxicol in Vitro."},{"issue":"13","key":"2849_CR199","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Instit. 1990;82(13):1107\u201312.","journal-title":"J Natl Cancer Instit."},{"key":"2849_CR200","doi-asserted-by":"crossref","unstructured":"Orellana EA, Kasinski AL. Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. Bio-protocol. 2016;6(21):Article e1984.","DOI":"10.21769\/BioProtoc.1984"},{"key":"2849_CR201","first-page":"10","volume":"54","author":"E Vega-Avila","year":"2011","unstructured":"Vega-Avila E, Pugsley MK. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc. 2011;54:10\u20134.","journal-title":"Proc West Pharmacol Soc."},{"issue":"1","key":"2849_CR202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10577-013-9340-5","volume":"21","author":"F Kohlmeier","year":"2013","unstructured":"Kohlmeier F, Maya-Mendoza A, Jackson DA. EdU induces DNA damage response and cell death in mESC in culture. Chromosome Res. 2013;21(1):87\u2013100.","journal-title":"Chromosome Res."},{"issue":"2","key":"2849_CR203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","volume":"24","author":"E Borenfreund","year":"1985","unstructured":"Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 1985;24(2):119\u201324.","journal-title":"Toxicol Lett."},{"issue":"7","key":"2849_CR204","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, Del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc. 2008;3(7):1125\u201331.","journal-title":"Nat Protoc."},{"key":"2849_CR205","doi-asserted-by":"crossref","unstructured":"Sadeh N, Oni-Biton E, Segal M. Acute live\/dead assay for the analysis of toxic effects of drugs on cultured neurons. Bio-protocol. 2016;6(15):Article e1889.","DOI":"10.21769\/BioProtoc.1889"},{"issue":"23","key":"2849_CR206","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.drudis.2010.07.007","volume":"15","author":"SJ Shukla","year":"2010","unstructured":"Shukla SJ, Huang R, Austin CP, Xia M. The future of toxicity testing: A focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today. 2010;15(23):997\u20131007.","journal-title":"Drug Discov Today."},{"issue":"1","key":"2849_CR207","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/adt.2013.520","volume":"12","author":"O Sirenko","year":"2014","unstructured":"Sirenko O, Hesley J, Rusyn I, Cromwell EF. High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol. 2014;12(1):43\u201354.","journal-title":"Assay Drug Dev Technol."},{"key":"2849_CR208","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-62703-002-1_15","volume-title":"Nanotoxicity: Methods and protocols","author":"F Tramer","year":"2012","unstructured":"Tramer F, Da Ros T, Passamonti S. Chapter 15: Screening of fullerene toxicity by hemolysis assay. In: Reineke J, editor. Nanotoxicity: Methods and protocols. Totowa: Humana Press; 2012. p. 203\u201317."},{"issue":"1","key":"2849_CR209","doi-asserted-by":"crossref","first-page":"20.2.1","DOI":"10.1002\/0471140856.tx2002s34","volume":"34","author":"A Pessina","year":"2007","unstructured":"Pessina A, Bonomi A. CFU-GM assay for evaluation of drug myelotoxic activity. Curr Protoc Toxicol. 2007;34(1):20.2.1\u201320.2.18.","journal-title":"Curr Protoc Toxicol."},{"key":"2849_CR210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6346-1_2","volume-title":"High-throughput screening assays in toxicology","author":"S Sakamuru","year":"2016","unstructured":"Sakamuru S, Attene-Ramos MS, Xia M. Mitochondrial membrane potential assay. In: Zhu H, Xia M, editors. High-throughput screening assays in toxicology. New York: Springer; 2016. p. 17\u201322."},{"issue":"1-2","key":"2849_CR211","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0027-5107(00)00064-6","volume":"455","author":"K Mortelmans","year":"2000","unstructured":"Mortelmans K, Zeiger E. The Ames Salmonella\/microsome mutagenicity assay. Mutat Res. 2000;455(1-2):29\u201360.","journal-title":"Mutat Res."},{"issue":"4","key":"2849_CR212","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymeth.2007.01.003","volume":"42","author":"P Houghton","year":"2007","unstructured":"Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, Lee CC. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods. 2007;42(4):377\u201387.","journal-title":"Methods."},{"issue":"1","key":"2849_CR213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10616-013-9664-1","volume":"67","author":"RT Pace","year":"2015","unstructured":"Pace RT, Burg KJL. Toxic effects of resazurin on cell cultures. Cytotechnology. 2015;67(1):13\u20137.","journal-title":"Cytotechnology."},{"key":"2849_CR214","doi-asserted-by":"crossref","unstructured":"Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2015;111(1):A3B1-A3B2.","DOI":"10.1002\/0471142735.ima03bs111"},{"issue":"1","key":"2849_CR215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00125565","volume":"1","author":"E Borenfreund","year":"1984","unstructured":"Borenfreund E, Borrero O. In vitro cytotoxicity assays. Potential alternatives to the Draize ocular allergy test. Cell Biol Toxicol. 1984;1(1):55\u201365.","journal-title":"Cell Biol Toxicol."},{"issue":"12","key":"2849_CR216","first-page":"193","volume":"1","author":"M Mennecozzi","year":"2012","unstructured":"Mennecozzi M, Landesmann B, Harris GA, Liska R, Whelan M. Hepatotoxicity screening taking a mode-of-action approach using HepaRG cells and HCA. ALTEX Proc. 2012;1(12):193\u2013204.","journal-title":"ALTEX Proc."},{"key":"2849_CR217","doi-asserted-by":"crossref","unstructured":"Boubaker-Elandalousi R, Mekni-Toujani M, Kaabi B, Larbi I, Diouani M-F, Gharbi M, et al. Non-cytotoxic Thymus capitata extracts prevent Bovine herpesvirus-1 infection in cell cultures. BMC Vet Res. 2014;10:Article 231.","DOI":"10.1186\/PREACCEPT-1942837218128489"},{"key":"2849_CR218","unstructured":"European Union Reference Laboratory for Alternatives to Animal Testing (EURL). Validated test methods. European Commission. 2020. Available from: https:\/\/ec.europa.eu\/jrc\/en\/eurl\/ecvam\/alternative-methods-toxicity-testing\/validated-test-methods. Accessed on: 30 May 2020."},{"issue":"1","key":"2849_CR219","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10520290312120004","volume":"78","author":"C Rodr\u00edguez-Burford","year":"2003","unstructured":"Rodr\u00edguez-Burford C, Oelschlager DK, Talley LI, Barnes MN, Partridge EE, Grizzle WE. The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines. Biotech Histochem. 2003;78(1):17\u201321.","journal-title":"Biotech Histochem."},{"key":"2849_CR220","first-page":"78","volume":"8","author":"M Singh","year":"2017","unstructured":"Singh M, McKenzie K, Ma X. Effect of dimethyl sulfoxide on in vitro proliferation of skin fibroblast cells. J Biotech Res. 2017;8:78\u201382.","journal-title":"J Biotech Res."},{"issue":"2","key":"2849_CR221","first-page":"161","volume":"62","author":"P Nygren","year":"1988","unstructured":"Nygren P, Larsson R, Lindh E, Rastad J, Akerstr\u00f6m G, Gylfe E. Dimethyl sulfoxide inhibits proliferation but not hypertrophy and functional dedifferentiation of bovine parathyroid cells in culture. Res Commun Chem Pathol Pharmacol. 1988;62(2):161\u201371.","journal-title":"Res Commun Chem Pathol Pharmacol."},{"issue":"3","key":"2849_CR222","first-page":"166","volume":"47","author":"S Vandhana","year":"2010","unstructured":"Vandhana S, Deepa PR, Aparna G, Jayanthi U, Krishnakumar S. Evaluation of suitable solvents for testing the anti-proliferative activity of triclosan - a hydrophobic drug in cell culture. Indian J Biochem Biophys. 2010;47(3):166\u201371.","journal-title":"Indian J Biochem Biophys."},{"issue":"4","key":"2849_CR223","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0045-6535(97)00131-8","volume":"35","author":"KO Yu","year":"1997","unstructured":"Yu KO, Fisher JW, Burton GA Jr, Tillitt DE. Carrier effects of dosing the H4IIE cells with 3,3',4,4\u00b4tetrachlorobiphenyl (PCB77) in dimethyl sulfoxide or isooctane. Chemosphere. 1997;35(4):895\u2013904.","journal-title":"Chemosphere."},{"key":"2849_CR224","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2016.09.029","volume":"96","author":"EA Mohamed","year":"2017","unstructured":"Mohamed EA, Abu Hashim II, Yusif RM, Suddek GM, Shaaban AAA, Badria FAE. Enhanced in vitro cytotoxicity and anti-tumor activity of vorinostat-loaded pluronic micelles with prolonged release and reduced hepatic and renal toxicities. Eur J Pharm Sci. 2017;96:232\u201342.","journal-title":"Eur J Pharm Sci."},{"issue":"1","key":"2849_CR225","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/10717544.2016.1256002","volume":"24","author":"V Piazzini","year":"2017","unstructured":"Piazzini V, Monteforte E, Luceri C, Bigagli E, Bilia AR, Bergonzi MC. Nanoemulsion for improving solubility and permeability of Vitex agnus-castus extract: Formulation and in vitro evaluation using PAMPA and Caco-2 approaches. Drug Deliv. 2017;24(1):380\u201390.","journal-title":"Drug Deliv."},{"issue":"5","key":"2849_CR226","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10616-012-9530-6","volume":"65","author":"M Timm","year":"2013","unstructured":"Timm M, Saaby L, Moesby L, Hansen EW. Considerations regarding use of solvents in in vitro cell based assays. Cytotechnology. 2013;65(5):887\u201394.","journal-title":"Cytotechnology."},{"issue":"1","key":"2849_CR227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.11.004","volume":"535","author":"Y Xie","year":"2018","unstructured":"Xie Y, Yao Y. Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide. Int J Pharm. 2018;535(1):157\u201363.","journal-title":"Int J Pharm."},{"key":"2849_CR228","doi-asserted-by":"crossref","unstructured":"Jamalzadeh L, Ghafoori H, Sariri R, Rabuti H, Nasirzade J, Hasani H, et al. Cytotoxic effects of some common organic solvents on MCF-7, RAW-264.7 and human umbilical vein endothelial cells. Avicenna J Med Biochem. 2016;4(1):Article e33453.","DOI":"10.17795\/ajmb-33453"},{"issue":"4","key":"2849_CR229","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/jac\/dky555","volume":"74","author":"A Kumar","year":"2019","unstructured":"Kumar A, Boradia VM, Thakare R, Singh AK, Gani Z, Das S, et al. Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial. J Antimicrob Chemother. 2019;74(4):912\u201320.","journal-title":"J Antimicrob Chemother."},{"issue":"10","key":"2849_CR230","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","volume":"11","author":"PY Muller","year":"2012","unstructured":"Muller PY, Milton MN. The determination and interpretation of the therapeutic index in drug development. Nat Rev Drug Discov. 2012;11(10):751\u201361.","journal-title":"Nat Rev Drug Discov."},{"issue":"2","key":"2849_CR231","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/bm401794p","volume":"15","author":"A King","year":"2014","unstructured":"King A, Chakrabarty S, Zhang W, Zeng X, Ohman DE, Wood LF, et al. High antimicrobial effectiveness with low hemolytic and cytotoxic activity for PEG\/quaternary copolyoxetanes. Biomacromolecules. 2014;15(2):456\u201367.","journal-title":"Biomacromolecules."},{"issue":"8","key":"2849_CR232","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4155\/fmc.10.224","volume":"2","author":"PK Vaddady","year":"2010","unstructured":"Vaddady PK, Lee RE, Meibohm B. In vitro pharmacokinetic\/pharmacodynamic models in anti-infective drug development: focus on TB. Future Med Chem. 2010;2(8):1355\u201369.","journal-title":"Future Med Chem."},{"issue":"3","key":"2849_CR233","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.drudis.2016.10.009","volume":"22","author":"S Ekins","year":"2017","unstructured":"Ekins S, Spektor AC, Clark AM, Dole K, Bunin BA. Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB). Drug Discov Today. 2017;22(3):555\u201365.","journal-title":"Drug Discov Today."},{"issue":"8","key":"2849_CR234","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2950","volume":"8","author":"FE Koehn","year":"2009","unstructured":"Koehn FE. Drug discovery from natural products. Nat Rev Drug Discov. 2009;8(8):678.","journal-title":"Nat Rev Drug Discov."},{"issue":"4","key":"2849_CR235","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/AAC.01152-07","volume":"52","author":"CF Pope","year":"2008","unstructured":"Pope CF, O'Sullivan DM, McHugh TD, Gillespie SH. A practical guide to measuring mutation rates in antibiotic resistance. Antimicrob Agents Chemother. 2008;52(4):1209\u201314.","journal-title":"Antimicrob Agents Chemother."},{"issue":"1","key":"2849_CR236","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.chembiol.2015.11.008","volume":"23","author":"BK Wagner","year":"2016","unstructured":"Wagner BK, Schreiber SL. The power of sophisticated phenotypic screening and modern mechanism-of-action methods. Cell Chem Biol. 2016;23(1):3\u20139.","journal-title":"Cell Chem Biol."},{"issue":"22","key":"2849_CR237","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1021\/jm500734a","volume":"57","author":"GF Pauli","year":"2014","unstructured":"Pauli GF, Chen S-N, Simmler C, Lankin DC, G\u00f6decke T, Jaki BU, et al. Importance of purity evaluation and the potential of quantitative 1H NMR as a purity assay. J Med Chem. 2014;57(22):9220\u201331.","journal-title":"J Med Chem."},{"key":"2849_CR238","doi-asserted-by":"crossref","unstructured":"Baell JB. Feeling Nature's PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS). J Nat Prod. 2016;79(3):616-628.","DOI":"10.1021\/acs.jnatprod.5b00947"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02849-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02849-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02849-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T19:50:36Z","timestamp":1623354636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02849-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":238,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02849-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"25 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"125"}}